<DOC>
	<DOCNO>NCT00244530</DOCNO>
	<brief_summary>To compare renal function ( 51Cr-EDTA clearance ) 48 hour post open-heart surgery ( coronary bypass valve surgery ) patient impaired renal function randomization either nifedipine infusion start surgery follow 24 hour placebo ( 0.9 % saline infusion ) . Study hypothesis nifedipine prophylactic effect decline renal function .</brief_summary>
	<brief_title>Prophylactic Effect Nifedipine Further Decline Renal Function Patients Undergoing Open-Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>1 . Patients either gender 18 year age . 2 . Patients significant coronary stenosi ( e ) ( ≥ 75 % coronary artery lumen surface stenosi ( e ) / aortic mitral valve vitriuim accept coronary artery bypass surgery and/or valve replacement surgery . 3 . Patients impaired renal function , define increase serum creatinine . Men : ≥ 150 µmol/l Women : ≥130 µmol/l . 1 . Patients maintenance hemodialysis 2 . Renal transplant patient 3 . Patients ejection fraction ≤ 35 % 4 . Patients unstable angina pectoris</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Preventive Therapy</keyword>
	<keyword>Calcium Channel Blockers</keyword>
	<keyword>Kidney Failure , Chronic</keyword>
	<keyword>Coronary Artery Bypass</keyword>
	<keyword>Heart Valve Prosthesis Implantation</keyword>
</DOC>